对抗精神病剂量和多药物的多基因责任 - 一个现实世界的注册和生物银行研究
Elise Koch1, Anders Kämpe2, Maris Alver3
1NORMENT, Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. e.m.koch@medisin.uio.no.
概括
精神分裂症的遗传风险与更高的抗精神病剂量和多药性有关. 这项研究使用了来自北欧队列的真实世界数据,表明遗传学可以为个性化抗精神病治疗策略提供信息.
科学领域:
- 精神病学是一个精神病学.
- 药物基因组学 药物基因组学
- 精准医学是一门精准的医学.
背景情况:
- 基因组对抗精神病治疗反应的预测,包括剂量和多药性,由于有限的大规模遗传和处方数据而具有挑战性.
- 现实世界的数据为在临床实践中调查遗传关联提供了宝贵的资源.
研究的目的:
- 调查精神分裂症的遗传责任与抗精神病剂量/多药剂量之间的关联.
- 探索多基因风险评分 (PRS) 在预测不同北欧群体治疗需求中的有用性.
主要方法:
- 利用了来自五个独立的北欧群体 (N=21,572) 的现实世界注册和生物银行数据,这些群体患有精神疾病.
- 采用回归模型来分析精神分裂症PRS与标准化抗精神病剂量和多药 (≥2种抗精神病药物) 之间的关系.
- 数据来源包括纵向处方注册表,健康记录和自我报告信息.
主要成果:
- 在精神分裂症PRS和处方抗精神病剂量 (β=0.0435,p=0.0006) 之间发现了显著的积极关联.
- 精神分裂症PRS也与抗精神病药物多药学有显著的关联 (OR=1.10,p=0.0073).
- 在所有五个队伍中观察到一致的效应方向.
结论:
- 遗传因素,特别是精神分裂症的PRS,与更高的抗精神病剂量和多药性有关.
- 这些发现支持利用遗传信息来指导个性化抗精神病治疗决策的潜力.
- 现实世界的数据有助于在精神病治疗中开发精准医学方法.
相关概念视频
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
150
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
150
01:26Psychosis: Goals of Pharmacotherapy
135
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
135
01:28Psychosis and Antipsychotic Drugs: Overview
271
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
271
01:12Analysis of Population Pharmacokinetic Data
264
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
264
01:21Antipsychotic Drugs: Typical and Atypical Agents
204
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
204